Annual CFO
-$50.22 M
+$9.64 M+16.10%
31 December 2023
Summary:
Verona Pharma annual cash flow from operations is currently -$50.22 million, with the most recent change of +$9.64 million (+16.10%) on 31 December 2023. During the last 3 years, it has fallen by -$5.15 million (-11.42%). VRNA annual CFO is now -1477217.65% below its all-time high of $3400.00, reached on 31 December 2005.VRNA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$62.66 M
-$45.55 M-266.36%
30 September 2024
Summary:
Verona Pharma quarterly cash flow from operations is currently -$62.66 million, with the most recent change of -$45.55 million (-266.36%) on 30 September 2024. Over the past year, it has dropped by -$49.93 million (-392.30%). VRNA quarterly CFO is now -374.50% below its all-time high of $22.82 million, reached on 30 September 2021.VRNA Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$103.77 M
-$49.93 M-92.73%
30 September 2024
Summary:
Verona Pharma TTM cash flow from operations is currently -$103.77 million, with the most recent change of -$49.93 million (-92.73%) on 30 September 2024. Over the past year, it has dropped by -$56.21 million (-118.19%). VRNA TTM CFO is now -2254.05% below its all-time high of -$4.41 million, reached on 31 March 2017.VRNA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRNA Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.1% | -392.3% | -118.2% |
| 3 y3 years | -11.4% | -374.5% | -198.8% |
| 5 y5 years | -118.5% | -645.6% | -178.3% |
VRNA Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -51.0% | +16.1% | -374.5% | at low | -263.8% | at low |
| 5 y | 5 years | -118.5% | +16.1% | -374.5% | at low | -263.8% | at low |
| alltime | all time | <-9999.0% | +16.1% | -374.5% | at low | -2254.1% | at low |
Verona Pharma Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$62.66 M(+266.4%) | -$103.77 M(+92.7%) |
| June 2024 | - | -$17.10 M(+25.7%) | -$53.84 M(-7.3%) |
| Mar 2024 | - | -$13.61 M(+30.8%) | -$58.05 M(+15.6%) |
| Dec 2023 | -$50.22 M(-16.1%) | -$10.40 M(-18.3%) | -$50.22 M(+5.6%) |
| Sept 2023 | - | -$12.73 M(-40.3%) | -$47.56 M(-10.1%) |
| June 2023 | - | -$21.31 M(+268.6%) | -$52.93 M(+3.5%) |
| Mar 2023 | - | -$5.78 M(-25.3%) | -$51.13 M(-14.6%) |
| Dec 2022 | -$59.86 M(+80.0%) | -$7.74 M(-57.2%) | -$59.86 M(-13.8%) |
| Sept 2022 | - | -$18.09 M(-7.3%) | -$69.45 M(+143.4%) |
| June 2022 | - | -$19.52 M(+34.5%) | -$28.53 M(-2.4%) |
| Mar 2022 | - | -$14.51 M(-16.2%) | -$29.21 M(-12.1%) |
| Dec 2021 | -$33.25 M(-26.2%) | -$17.32 M(-175.9%) | -$33.25 M(-4.2%) |
| Sept 2021 | - | $22.82 M(-213.0%) | -$34.73 M(-48.6%) |
| June 2021 | - | -$20.20 M(+8.9%) | -$67.55 M(+34.0%) |
| Mar 2021 | - | -$18.55 M(-1.3%) | -$50.40 M(+11.8%) |
| Dec 2020 | -$45.08 M(+5.2%) | -$18.80 M(+88.0%) | -$45.08 M(+19.1%) |
| Sept 2020 | - | -$10.00 M(+226.6%) | -$37.83 M(+4.4%) |
| June 2020 | - | -$3.06 M(-76.9%) | -$36.24 M(-16.2%) |
| Mar 2020 | - | -$13.22 M(+14.5%) | -$43.23 M(+0.8%) |
| Dec 2019 | -$42.87 M | -$11.55 M(+37.5%) | -$42.87 M(+15.0%) |
| Sept 2019 | - | -$8.40 M(-16.4%) | -$37.29 M(+25.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | - | -$10.05 M(-21.9%) | -$29.75 M(+9.8%) |
| Mar 2019 | - | -$12.86 M(+115.5%) | -$27.11 M(+17.9%) |
| Dec 2018 | -$22.98 M(-17.8%) | -$5.97 M(+585.6%) | -$22.98 M(-3.6%) |
| Sept 2018 | - | -$870.80 K(-88.2%) | -$23.83 M(-28.9%) |
| June 2018 | - | -$7.40 M(-15.3%) | -$33.50 M(+3.7%) |
| Mar 2018 | - | -$8.74 M(+28.1%) | -$32.30 M(+15.5%) |
| Dec 2017 | -$27.97 M(+305.8%) | -$6.82 M(-35.3%) | -$27.97 M(+32.3%) |
| Sept 2017 | - | -$10.54 M(+69.9%) | -$21.15 M(+99.3%) |
| June 2017 | - | -$6.20 M(+40.7%) | -$10.61 M(+140.7%) |
| Mar 2017 | - | -$4.41 M | -$4.41 M |
| Dec 2016 | -$6.89 M(-26.8%) | - | - |
| Dec 2015 | -$9.42 M(+70.9%) | - | - |
| Dec 2014 | -$5.51 M(+62.7%) | - | - |
| Dec 2013 | -$3.39 M(-17.0%) | - | - |
| Dec 2012 | -$4.08 M(+67.0%) | - | - |
| Dec 2011 | -$2.44 M(-4.6%) | - | - |
| Dec 2010 | -$2.56 M(-2.3%) | - | - |
| Dec 2009 | -$2.62 M(+32.6%) | - | - |
| Dec 2008 | -$1.98 M(-17.3%) | - | - |
| Dec 2007 | -$2.39 M(+247.5%) | - | - |
| Dec 2006 | -$687.70 K(<-9900.0%) | - | - |
| Dec 2005 | $3400.00 | - | - |
FAQ
- What is Verona Pharma annual cash flow from operations?
- What is the all time high annual CFO for Verona Pharma?
- What is Verona Pharma annual CFO year-on-year change?
- What is Verona Pharma quarterly cash flow from operations?
- What is the all time high quarterly CFO for Verona Pharma?
- What is Verona Pharma quarterly CFO year-on-year change?
- What is Verona Pharma TTM cash flow from operations?
- What is the all time high TTM CFO for Verona Pharma?
- What is Verona Pharma TTM CFO year-on-year change?
What is Verona Pharma annual cash flow from operations?
The current annual CFO of VRNA is -$50.22 M
What is the all time high annual CFO for Verona Pharma?
Verona Pharma all-time high annual cash flow from operations is $3400.00
What is Verona Pharma annual CFO year-on-year change?
Over the past year, VRNA annual cash flow from operations has changed by +$9.64 M (+16.10%)
What is Verona Pharma quarterly cash flow from operations?
The current quarterly CFO of VRNA is -$62.66 M
What is the all time high quarterly CFO for Verona Pharma?
Verona Pharma all-time high quarterly cash flow from operations is $22.82 M
What is Verona Pharma quarterly CFO year-on-year change?
Over the past year, VRNA quarterly cash flow from operations has changed by -$49.93 M (-392.30%)
What is Verona Pharma TTM cash flow from operations?
The current TTM CFO of VRNA is -$103.77 M
What is the all time high TTM CFO for Verona Pharma?
Verona Pharma all-time high TTM cash flow from operations is -$4.41 M
What is Verona Pharma TTM CFO year-on-year change?
Over the past year, VRNA TTM cash flow from operations has changed by -$56.21 M (-118.19%)